Looking for Sentiment Analysis? Discover the most popular stocks on Reddit by using our Sentiment Tracker
Market Cap 55.58M P/E - EPS this Y 12.40% Ern Qtrly Grth -
Income -30.19M Forward P/E -1.84 EPS next Y 30.40% 50D Avg Chg -14.00%
Sales 71.35M PEG - EPS past 5Y - 200D Avg Chg -50.00%
Dividend N/A Price/Book 1.15 EPS next 5Y - 52W High Chg -72.00%
Recommedations 2.20 Quick Ratio 4.00 Shares Outstanding 29.97M 52W Low Chg 3.00%
Insider Own 6.32% ROA -15.34% Shares Float 21.34M Beta 2.44
Inst Own 65.19% ROE -66.17% Shares Shorted/Prior 57.69K/53.18K Price 1.95
Gross Margin 75.13% Profit Margin -42.31% Avg. Volume 144,532 Target Price 7.00
Oper. Margin -11.95% Earnings Date May 7 Volume 93,241 Change -0.51%
About Neuronetics, Inc.

Neuronetics, Inc., a commercial stage medical technology company, designs, develops, and markets products for patients with neurohealth disorders in the United States and internationally. The company offers NeuroStar Advanced Therapy System, a non-invasive and non-systemic office-based treatment to treat adult patients with major depressive disorder. Its NeuroStar Advanced Therapy System uses transcranial magnetic stimulation to create a pulsed, MRI-strength magnetic field that induces electrical currents designed to stimulate specific areas of the brain associated with mood. The company sells its products through its sales and customer support team to psychiatrists. The company was incorporated in 2001 and is headquartered in Malvern, Pennsylvania.

Neuronetics, Inc. News
05/01/24 NeuroStar® TMS Advances Treatment for Adolescents During Mental Health Awareness Month
04/23/24 Neuronetics to Report First Quarter 2024 Financial and Operating Results and Host Conference Call
04/10/24 New Publication in Brain Stimulation Confirms Full TMS Treatment Course Is Vital
04/01/24 Neuronetics' (STIM) FDA-Cleared NeuroStar to Aid in Depression
03/27/24 Neuronetics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
03/27/24 Neuronetics wins FDA clearance for device to treat adolescents with depression
03/25/24 NeuroStar® Advanced Therapy Receives FDA Clearance as a First-Line Add-On Treatment for Adolescents with Depression
03/08/24 Neuronetics (STIM) Progresses in MRD and TRD With New Deal
03/07/24 Neuronetics Inc (STIM) Reports Record Revenues in Q4 and Full Year 2023
03/07/24 Neuronetics, Inc. (NASDAQ:STIM) Q4 2023 Earnings Call Transcript
03/07/24 Neuronetics Announces 5-Year Exclusive Partnership with Transformations Care Network
03/06/24 Neuronetics Full Year 2023 Earnings: US$1.05 loss per share (vs US$1.38 loss in FY 2022)
03/05/24 Q4 2023 Neuronetics Inc Earnings Call
03/05/24 Neuronetics (STIM) Reports Q4 Loss, Tops Revenue Estimates
03/05/24 Neuronetics Reports Record Fourth Quarter and Record Full Year 2023 Financial and Operating Results
02/20/24 Neuronetics to Report Fourth Quarter 2023 Financial and Operating Results and Host Conference Call
02/15/24 Artivion (AORT) Surpasses Q4 Earnings and Revenue Estimates
02/12/24 Neuronetics Launches Latest Evolution in its TrakStar® Patient Data Management System
02/06/24 NeuroStar TMS Patient Access Expands Through Lucet Health Policy Update
01/23/24 After losing 41% in the past year, Neuronetics, Inc. (NASDAQ:STIM) institutional owners must be relieved by the recent gain
STIM Chatroom

User Image Boriqua Posted - 19 hours ago

$STIM https://finance.yahoo.com/news/neurostar-tms-advances-treatment-adolescents-123100627.html

User Image Stock_Titan Posted - 04/23/24

$STIM Neuronetics to Report First Quarter 2024 Financial and Operating Results and Host Conference Call https://www.stocktitan.net/news/STIM/neuronetics-to-report-first-quarter-2024-financial-and-operating-0ibakdlvsbs3.html

User Image HassanIsBack Posted - 04/18/24

$STIM this board is so boring is anyone even here

User Image wisdon Posted - 04/13/24

$ZOM PETER SHOW YOUR LEADER POWER LIKE IN $TFX $STIM & MUCH MORE GL https://zomedica.com/about-zomedica/peter-l-donato/

User Image chris8may1982 Posted - 04/12/24

$STIM 👏👏👏 never lets you down

User Image Glizzy_Gladiator Posted - 04/10/24

$STIM Now we wait

User Image DonCorleone77 Posted - 04/10/24

$STIM 2 of 2 - Neuronetics announces publication of findings in Brain Stimulation ....Insurers, practitioners, and patients can all take note that patients who are slow to respond to the treatment process still have a significant likelihood of improving by the end of their full course. This paper builds upon prior publications utilizing data from our proprietary TrakStar database, which showed a correlation between treatment sessions completed and positive clinical outcomes. Treating to completion of 36 NeuroStar sessions offers patients the greatest potential to benefit from NeuroStar TMS treatment."

User Image DonCorleone77 Posted - 04/10/24

$STIM 1 of 2 - Neuronetics announces publication of findings in Brain Stimulation Neuronetics announced the publication of significant clinical findings in Brain Stimulation: Basic, Translational, and Clinical Research in Neuromodulation, the premier journal in the field of neuromodulation. This analysis concludes that while early symptom improvement in major depressive disorder is strongly predictive of response at the completion of transcranial magnetic stimulation treatment, lack of early improvement does not predict final treatment outcome. "These findings provide hope for practitioners and patients alike that a lack of improvement early in a TMS treatment regimen does not predict final non-response status, reinforcing the importance of completing the full prescribed treatment course for maximum results," said Cory Anderson, Senior Vice President of Research & Development and Clinical, Neuronetics....

User Image Stock_Titan Posted - 04/10/24

$STIM New Publication in Brain Stimulation Confirms Full TMS Treatment Course Is Vital https://www.stocktitan.net/news/STIM/new-publication-in-brain-stimulation-confirms-full-tms-treatment-0ec5zl9wlxgk.html

User Image mikelegion Posted - 04/05/24

@CantNameThatTune can you provide your analysis on $STIM. Love the way you detail your DD

User Image Stocks4thought Posted - 1 month ago

$STIM I thought she'd love five?

User Image Buy1234 Posted - 1 month ago

$STIM 🚀🚀

User Image Stocks4thought Posted - 1 month ago

$STIM $

User Image sam92 Posted - 03/27/24

$STIM 3/26/24 William Blair STIM Neuronetics, Inc. Market Perform Separately, Piper Sandler reaffirmed an "overweight" rating and set a $8.00 target price (up from $7.00) on shares of Neuronetics in a report on Wednesday, March 6th.

User Image Stock_Titan Posted - 03/27/24

$STIM Neuronetics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) https://www.stocktitan.net/news/STIM/neuronetics-reports-inducement-grant-under-nasdaq-listing-rule-5635-yixhndfbg7aq.html

User Image eq2 Posted - 03/26/24

$STIM

User Image EingeLTrade Posted - 03/26/24

$STIM jumping of trend re-test

User Image Duque_B Posted - 03/25/24

$STIM that $60MM term loan that’s being amortized is going to eat into cash for 2024 if new revenue doesn’t materialize. Offering this year possible

User Image biostock Posted - 03/25/24

$STIM Almost got there in premarket.

User Image Stocks4thought Posted - 03/25/24

$STIM This changes the customer base tremendously- how quick an uptake and revenue translation. Honestly, missed the early gains in stock- was watching $BWAY any help?

User Image _StockTrader Posted - 03/25/24

Real-Time Stock Data $STIM Price: 4.71 Volume: 718627 Market Cap: 138663424 PE Ratio: -7.28125 Powered by: AITX

User Image ReadyToMakeMula Posted - 03/25/24

$STIM $MBOT $PTPI $EVAX $MAIA Blocked.

User Image Stocksrunner Posted - 03/25/24

🚀📈 Monday Market Movers! $TH is on fire! 🏠 Jumping after a $10.80 per share takeover offer. $NKTX is shooting for the stars! 🌟 With a +20% surge after announcing a $240 million offering. $ESPR With FDA approval for new heart attack prevention labels, shares are on the rise. $STIM FDA clearance for NeuroStar therapy in adolescent depression treatment. Innovative solutions, bullish results!

User Image STCG Posted - 03/25/24

$STIM Selling this stock last month has been my biggest stock trading regret of 2024. Congrats bulls.

User Image eq2 Posted - 03/25/24

$STIM

User Image JFZ Posted - 03/25/24

$STIM 👀

User Image StockMET Posted - 03/25/24

$STIM gap fill ✅ congrats team!!! Let’s make some new gains this week 💰💰

User Image Prosperity_Trades Posted - 03/25/24

Our watchlist as of this morning: $CYTO $FLGC $MLGO $LCID $STIM https://whop.com/prosperity-trades/

User Image sam92 Posted - 03/25/24

$STIM $RUT $SPX $DJIA "RAMPERS CLUB " STIM Major News Alert ! Reuters NeuroStar® Advanced Therapy Receives FDA Clearance as a First-Line Add-On Treatment for Adolescents with Depression Mar 25, 202408:30 EDT https://www.tradingview.com/news/reuters.com,2024-03-25:newsml_GNX10mrXF:0-neurostar-advanced-therapy-receives-fda-clearance-as-a-first-line-add-on-treatment-for-adolescents-with-depression/

User Image shared_alerts Posted - 03/25/24

-03/25/2024- 📉 MORNING GAPPERS CONT 📈 $LCID $STIM $NKTX $FRGE ↩️

Analyst Ratings
Piper Sandler Overweight Mar 6, 24
JMP Securities Market Outperform May 10, 23
Canaccord Genuity Buy Mar 8, 23
JMP Securities Market Outperform Mar 8, 23
JMP Securities Market Outperform Oct 14, 21
BTIG Neutral Oct 13, 21
William Blair Outperform Jan 22, 21
Canaccord Genuity Buy Oct 26, 20
BTIG Buy Oct 6, 20
Insider Trades Relationship Date Transactions Cost($) #Shares Value($) #Share Own SEC Form 4
Sullivan Keith J President and CEO President and CEO Jan 10 Sell 3.09 19,529 60,345 1,158,129 01/12/24
MACAN WILLIAM ANDREW EVP, GC, CCO and CS EVP, GC, CCO and CS Dec 19 Sell 2.49 34,991 87,128 348,742 12/21/23
MACAN WILLIAM ANDREW EVP, GC, CCO and CS EVP, GC, CCO and CS Oct 06 Sell 1.155 1,469 1,697 383,733 10/10/23
Furlong Stephen EVP, CFO and Treasur.. EVP, CFO and Treasurer Oct 06 Sell 1.155 1,499 1,731 429,556 10/10/23
CASCELLA ROBERT Director Director Aug 10 Buy 1.813 28,500 51,670 162,848 09/20/23
Sullivan Keith J President and CEO President and CEO Jul 21 Sell 2.04 6,551 13,364 1,177,658 07/25/23
Sullivan Keith J President and CEO President and CEO Jul 19 Sell 2.07 12,989 26,887 1,184,209 07/21/23
MACAN WILLIAM ANDREW EVP, GC, CCO and CS EVP, GC, CCO and CS Jul 11 Sell 2.13 2,645 5,634 385,202 07/12/23
CANNELL CAPITAL LLC 10% Owner 10% Owner Mar 16 Buy 2.9 59,716 173,176 3,127,819 03/20/23
CANNELL CAPITAL LLC 10% Owner 10% Owner Mar 13 Buy 2.97 136,520 405,464 3,068,103 03/15/23
CANNELL CAPITAL LLC 10% Owner 10% Owner Mar 07 Sell 4.71 7,746 36,484 2,931,583 03/09/23
Furlong Stephen CFO CFO Feb 14 Sell 5.74 25,551 146,663 442,134 02/16/23
CANNELL CAPITAL LLC 10% Owner 10% Owner Jan 17 Sell 6.31 2,912 18,375 2,939,329 01/19/23
Furlong Stephen CFO CFO Jan 17 Sell 6.13 16,050 98,386 373,269 01/18/23
CANNELL CAPITAL LLC 10% Owner 10% Owner Jan 09 Sell 6.46 204,812 1,323,086 2,942,241 01/13/23
CANNELL CAPITAL LLC 10% Owner 10% Owner Dec 22 Sell 6.05 14,174 85,753 3,246,131 12/27/22
CANNELL CAPITAL LLC 10% Owner 10% Owner Dec 19 Sell 6.32 203,541 1,286,379 3,260,305 12/21/22
Furlong Stephen CFO CFO Jul 25 Sell 3.54 13,321 47,156 390,949 07/26/22
CANNELL CAPITAL LLC 10% Owner 10% Owner Jun 10 Buy 3.52 7,044 24,795 3,458,776 06/14/22
CANNELL CAPITAL LLC 10% Owner 10% Owner May 26 Buy 2.58 9,546 24,629 3,441,732 05/31/22
CANNELL CAPITAL LLC 10% Owner 10% Owner May 23 Buy 2.41 36,123 87,056 3,432,186 05/25/22
CANNELL CAPITAL LLC 10% Owner 10% Owner May 18 Buy 2.36 63,913 150,835 3,393,063 05/20/22
CANNELL CAPITAL LLC 10% Owner 10% Owner May 10 Buy 2.16 121,646 262,755 3,329,150 05/13/22
CANNELL CAPITAL LLC 10% Owner 10% Owner May 05 Buy 2.39 25,150 60,108 3,207,504 05/09/22
CANNELL CAPITAL LLC 10% Owner 10% Owner May 02 Buy 2.49 40,429 100,668 3,182,354 05/04/22
CANNELL CAPITAL LLC 10% Owner 10% Owner Apr 22 Buy 2.78 10,806 30,041 3,141,925 04/26/22
CANNELL CAPITAL LLC 10% Owner 10% Owner Apr 19 Buy 2.89 206 595 3,131,119 04/21/22
CANNELL CAPITAL LLC 10% Owner 10% Owner Apr 11 Buy 2.93 134,319 393,555 3,130,913 04/13/22
CANNELL CAPITAL LLC 10% Owner 10% Owner Apr 06 Buy 3.16 2,829 8,940 2,996,594 04/08/22
CANNELL CAPITAL LLC 10% Owner 10% Owner Mar 31 Buy 3 265,305 795,915 2,993,765 04/04/22
CANNELL CAPITAL LLC 10% Owner 10% Owner Mar 25 Buy 2.97 60,848 180,719 2,728,460 03/29/22
Furlong Stephen CFO CFO Mar 09 Sell 2.9959 10,029 30,046 404,270 03/10/22
Shook Bruce Joseph Director Director Nov 12 Option 4.06 7,797 31,656 37,734 11/16/21
Shook Bruce Joseph Director Director Nov 12 Sell 5.3 7,797 41,324 29,937 11/16/21